Correlated Drug Terms (2)

---

	Name (Synonyms)	Correlation
drug2381	Supportive Care Wiki	0.58
drug1822	Placebo Wiki	0.06

Correlated MeSH Terms (1)

---

	Name (Synonyms)	Correlation
D007239	Infection NIH	0.06

Correlated HPO Terms (0)

---

	Name (Synonyms)	Correlation

Primary Outcomes

Description: Respiratory failure-free survival rate 28 is defined as the proportion of patients who have not had respiratory failure nor died <= 28 days from randomization.

Measure: Respiratory failure-free survival rate at day 28

Time: 28 Days

---

Secondary Outcomes

Measure: Median reduction in days spent on supplemental oxygen

Time: Up to 28 Days

---

Measure: All-cause mortality

Time: Up to 28 Days

---

Measure: Proportion of participants experiencing respiratory failure or death

Time: Up to 28 Days

---

Measure: Mechanical ventilation-free survival

Time: Up to 28 Days

---

Measure: Days on mechanical ventilation

Time: Up to 28 Days

---

Measure: Duration of hospitalization

Time: Up to 28 Days

---

Measure: Time to discharge

Time: Up to 28 Days

---

Measure: PaO2:FiO2 and/or oxygenation index

Time: Up to 28 Days

---

Description: This scale evaluates the safety and efficacy of investigational therapeutic agents in combination with care for the treatment of hospitalized participants suffering from COVID-19 infections on a scale of scores from 0 to 8, with higher scores indicating higher level of severity of the disease. (0 = No clinical or virological evidence of disease, and 8 = Death)

Measure: Change from Baseline to Day 14 in WHO - 8 Point Ordinal Scale

Time: Up to 28 Days

---